Exact Mass: 614.106
Exact Mass Matches: 614.106
Found 64 metabolites which its exact mass value is equals to given mass value 614.106,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cytidine 5'-monophosphate-N-acetylneuraminic acid
Cytidine 5-monophosphate-N-acetylneuraminic acid (CMP-Neu5Ac), also known as CMP-N-acetyl-β-neuraminic acid, belongs to the class of organic compounds known as pyrimidine nucleotide sugars. These are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. CMP-Neu5Ac is an extremely weak basic (essentially neutral) compound (based on its pKa). CMP-Neu5Ac donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. A nucleoside monophosphate sugar which donates N-acetylneuraminic acid to the terminal sugar of a ganglioside or glycoprotein. [HMDB] COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables. 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is isolated from commercial rhubarbs (Rheum sp.). Isolated from commercial rhubarbs (Rheum species). 2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose is found in green vegetables.
6-Cinnamoyl-1,2-digalloylglucose
6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables. 6-Cinnamoyl-1,2-digalloylglucose is isolated from commercial rhubarbs (Rheum species). Isolated from commercial rhubarbs (Rheum subspecies). 6-Cinnamoyl-1,2-digalloylglucose is found in green vegetables.
Fosaprepitant
Fosaprepitant is only found in individuals that have used or taken this drug. It is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment.Aprepitant has been shown in animal models to inhibit emesis induced by cytotoxic chemotherapeutic agents, such as cisplatin, via central actions. Animal and human Positron Emission Tomography (PET) studies with Aprepitant have shown that it crosses the blood brain barrier and occupies brain NK1 receptors. Animal and human studies show that Aprepitant augments the antiemetic activity of the 5-HT3-receptor antagonist ondansetron and the corticosteroid ethasone and inhibits both the acute and delayed phases of cisplatin induced emesis.In summary, the active form of fosaprepitant is as an NK1 antagonist which is because it blocks signals given off by NK1 receptors. This therefore decreases the likelihood of vomiting in patients experiencing. D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
Cmp-nana
Lifitegrast
[(2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] (2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
1-Hydroxycrisamicin A
An organic heterotetracyclic compound isolated from the culture broth of Micromonospora sp. SA-246. It exhibits potent antibacterial activity against several Gram-positive bacterial strains.
4-galloyl-3,3-di-O-methylellagic acid 4-O-beta-D-xylopyranoside
3-methoxy-7-O-beta-(6-galloylglucopyranoside)quercetin
Fosaprepitant
D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
2-Cinnamoyl-1,6-digalloyl-beta-D-glucopyranose
6-Cinnamoyl-1,2-digalloylglucose
[3-(3-carboxypropanoylcarbamoylamino)-2-methoxypropyl]-(1,3-dimethyl-2,6-dioxo-4,5-dihydropurin-7-yl)mercury
Lifitegrast
D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions C78283 - Agent Affecting Organs of Special Senses S - Sensory organs > S01 - Ophthalmologicals
2,7-Dibromo-9,9-bis(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-9H-fluorene
[(2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] (2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate
6-[1-(7-Chloro-3,5,6,8-tetramethoxy-4-oxochromen-2-yl)-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
Cytidine monophosphate N-acetylneuraminic acid
COVID info from WikiPathways Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5-Acetamido-2-[[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid
2-deoxycytidine 5-monophosphate dimer
A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of 2-deoxycytidine 5-monophosphate.
CMP-N-Acetyl-beta-neuraminic acid
A nucleotide sugar used as a donor by glycosyltransferases for the synthesis of sugar chains
5,6-diamino-1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-4,5-dihydro[4,4-bipyrimidine]-2,2(1H,3H)-dione
An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.
1,3-bis(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-6-(5,6-diamino-2-oxo-2,3,4,5-tetrahydropyrimidin-4-yl)-1,3-diazabicyclo[2.2.0]hex-4-en-2-one
An N-glycosyl compound that is a metabolite produced by the bacterium Mycoplasma genitalium.
(E)-Akt inhibitor-IV
(E)-Akt inhibitor-IV ((E)-AKTIV) is a PI3K-Akt inhibitor, with potent cytotoxic[1].
(11s,15s,17r)-7,17-dihydroxy-5-[(11s,15s,17s)-7-hydroxy-17-methyl-2,9,13-trioxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraen-5-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
7'-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-7-hydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione
3,5-dihydroxy-2-{3-hydroxy-4-[2-methoxy-4-(3,5,7-trihydroxy-4-oxochromen-2-yl)phenoxy]phenyl}-7-methoxychromen-4-one
methyl (1r,12r,13r,17s,27s)-27-(acetyloxy)-5,9,12,20,22-pentahydroxy-24-methyl-7,18-dioxo-14-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0²¹,²⁶]nonacosa-3(16),4,6(15),8,10,19,21,23,25,28-decaene-13-carboxylate
17-methyl-5-{2,7,9-trihydroxy-17-methyl-13-oxo-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1,3,5,7,9-pentaen-5-yl}-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),5-triene-2,4,7,9,13-pentone
7,14-dimethoxy-3,10-dioxo-13-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4,6,8(16),11,13-hexaen-6-yl 3,4,5-trihydroxybenzoate
1,6-digalloyl-2-cinnamoyl-glucose
{"Ingredient_id": "HBIN001857","Ingredient_name": "1,6-digalloyl-2-cinnamoyl-glucose","Alias": "1-O,6-O-Digalloyl-2-O-cinnamoyl-beta-D-glucopyranose; [(2R,3S,4S,5R,6S)-3,4-dihydroxy-5-[(E)-3-phenylprop-2-enoyl]oxy-6-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate; AC1O3D78","Ingredient_formula": "C29H26O15","Ingredient_Smile": "C1=CC=C(C=C1)C=CC(=O)OC2C(C(C(OC2OC(=O)C3=CC(=C(C(=C3)O)O)O)COC(=O)C4=CC(=C(C(=C4)O)O)O)O)O","Ingredient_weight": "614.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15054","TCMID_id": "5513","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "6325082","DrugBank_id": "NA"}
